Upload
rushda
View
217
Download
0
Embed Size (px)
Citation preview
7/23/2019 Dermatotherapy
1/56
TOPICAL DERMATOTHERAPYTOPICAL DERMATOTHERAPY
Dr. dr. Farida Tabri, Sp.KK(K)
7/23/2019 Dermatotherapy
2/56
The main requirement for
topical dermatotherapy is
selection of the suitable base,
also called vehicle.
7/23/2019 Dermatotherapy
3/56
Vehicle is used for those
substance that bring
specific drugs into contact
with the skin.
7/23/2019 Dermatotherapy
4/56
The most important vehicles
for topical use divided into :
I. Monophasic Vehicles.
II. iphasic Vehicles.
III. Triphasic Vehicles.
7/23/2019 Dermatotherapy
5/56
!"#$%&
!"#$%&
"I' ( )*T
"I' ( )*T 'I+I$
'I+I$
-ool
!asta
-ool
!asta!*T*
!*T* '"TI"/
'"TI"/
MPORTANT BASES FOR TOP CAL
TREATMENT
%M'TI"/ :
-&%*M 0" ( #1"I/TM%/T 0# ( "1
%M'TI"/ :
-&%*M 0" ( #1"I/TM%/T 0# ( "1
7/23/2019 Dermatotherapy
6/56
*. ' I + I $*. ' I + I $
. Monophasic Vehicles
2. aths :
%ffect cleansing effect
0crusts, scales, secretions1.
7/23/2019 Dermatotherapy
7/56
%3ample : full bath, sit bath,
foot bath, hand bath.
ide effect : maceration
0limited 45 minutes1.
!reparation:
ol acid salicyl.
ol kalium permanganate.
7/23/2019 Dermatotherapy
8/56
6. #et $ressing
Type:
"pen wet dressing
rapid evaporation.
-losed wet dressing
retards evaporation.
7/23/2019 Dermatotherapy
9/56
Indicated : superficial,
inflammatory, crusted, 7erosive skin lesions.
%ffect:
-ooling.
&educes swelling.
*nti8inflammatory.
oftening 7 removing
accretion.
7/23/2019 Dermatotherapy
10/56
ide %ffect:
Maceration.
Increase in bacterial
growth.
7/23/2019 Dermatotherapy
11/56
%ffect:
-overing protective.
-ooling.
*nti8frictional.
uperficial anti8inflammatory.
$rying.
. ! " # $ % &. ! " # $ % &
7/23/2019 Dermatotherapy
12/56
Indicated:
uperficial $ermatoses.
%rythematous %3anthema.
Vesicle or bullae
protective.
-ontraindicated : Madidans
lesion.
7/23/2019 Dermatotherapy
13/56
pecifics drugs contain:
9inc o3ide.
Magnesium o3ide.
Titanium o3ide.
ismuth subnitrate0preputial area1.
7/23/2019 Dermatotherapy
14/56
ynonyms : shake lotion,
liquid powder mi3ture.
$efinition : suspensions of
solid material in water or
ethanol two phase systems.
. Biphasic Vehicles
*. ' " T I " /*. ' " T I " /
7/23/2019 Dermatotherapy
15/56
%ffects:
-ooling.
*stringents.
$rying.
uperficial anti8inflammatory.
7/23/2019 Dermatotherapy
16/56
Indicated:
*cute, sub8acute 7
superficial inflammatory
dermatoses.
eborrheic 7 intertrigenousdermatoses.
7/23/2019 Dermatotherapy
17/56
ide effect:
$rying action indicatedfor short term use.
*brasive the powderparticle may clump.
-ommercial preparations:
-alamine !.
-aladryl lotion.
7/23/2019 Dermatotherapy
18/56
ynonym: hydrophilic cream.
$efinition : emulsion of oil in
water 0" ( #1, a two phase
systems of water 7 fatty
substances.
. - & % * M. - & % * M
7/23/2019 Dermatotherapy
19/56
%ffects :
-ooling.
*nti8inflammatory effect.
Moisturiing 7 emollient
effect.
&apidly penetrate the skin.
#ater washable.
7/23/2019 Dermatotherapy
20/56
Indicated:
$ermatitis acute ( sub8
acute.
-osmetic indication
0cleansing or bodylotion1.
7/23/2019 Dermatotherapy
21/56
-ontraindicated:
$ry skin condition.Madidans lesion.
ide effect:!romote drying 0prolong
application1.
!ruritic effect 0because
evaporated tendency1
7/23/2019 Dermatotherapy
22/56
ynonym: lipophilic cream.
$efinition : emulsions of
water in oil 0# ( "1, a two
phase systems of fat and a
limited amount of water
0about 45;1.
-. " I / T M % / T-. " I / T M % / T
7/23/2019 Dermatotherapy
23/56
%ffect:
-overing.
oftening scales 7
crusts.
7/23/2019 Dermatotherapy
24/56
-ontraindicated:
eborrheic condition.
*cute inflammatory skin
0Madidans lesion1. ide effect:
!romote inflammation
occlusion effect.
!romote dyhidrosis.
7/23/2019 Dermatotherapy
25/56
$efinition : ointment into
which 65 8 =5; powder, atwo phase system or as
highly concentratedsuspensions.
$. ! * T *$. ! * T *
7/23/2019 Dermatotherapy
26/56
%ffects:
-ooling.
*nti8inflammatory.
ecretion > absorbing
0drying1.
kin protective action.
7/23/2019 Dermatotherapy
27/56
Indicated :
lcers.
-hronic e3udative
dermatoses.
Thick lichenified plaque.
econdary bacterial
infection.
7/23/2019 Dermatotherapy
28/56
-ontraindicated :
*cute inflammatory
skin.
calp skin.
7/23/2019 Dermatotherapy
29/56
$efinition : triphasic
vehicles that consist of oil
> water > powder mi3tures
in varying proportions.
. Triphasic Vehicles
-""'I/< !*T*-""'I/< !*T*
7/23/2019 Dermatotherapy
30/56
B.POWDER :
%ffects:
oothing.
-ooling.
#eeping skin.
The basic formula for cooling
pasta : inc o3ide, calcium
hydro3ide solution, 7 oil.
7/23/2019 Dermatotherapy
31/56
2. Tars.
6. ?eratolytic drug.
4. *ntibiotic drugs.
@. *nti8fungal drugs.
=. !arasiticides.
A. -orticosteroids.
Specific Topical Treatment
7/23/2019 Dermatotherapy
32/56
$efinition : are produces
by dry distillation of coal,
wood, or peat.
2. T * &2. T * &
7/23/2019 Dermatotherapy
33/56
%ffects :
*nti8pruritic.*nti8inflammatory.
?eratoplastic.
*nti8infective actions.
Indicated:
-hronic lichenified.
*topic ecema.
!soriasis vulgaris.
7/23/2019 Dermatotherapy
34/56
-ontraindicated : e3udative
or infection dermatoses. ide effects:
!hototo3ic dermatitis.Tar folliculitis.
Tar acne.-arcinogenicity of coal
tar 0long term use1.
7/23/2019 Dermatotherapy
35/56
a. alicylic acid
*t 'ow concentrations 05.= 8
6;1, it has an antiseptic,
keratoplastic, an anti8
inflammatory action.
6. ?%&*T"'BTI- $&
7/23/2019 Dermatotherapy
36/56
*t a concentration of 4 8
25;, it has keratolytics,loosen scales in psoriasis or
hyperkeratotic ecema.
ide effect : to3ic effect is
used in large area
0especially : children1.
7/23/2019 Dermatotherapy
37/56
b.ulfur
%ffect :
*stringent action 06 8 25;1.
*n anti8fungal 025;1.
-osmetic 7 medical facial
7 scalp preparation 0no
sebum suppressive effect1.
7/23/2019 Dermatotherapy
38/56
c. &esorcinol
%ffect:
$rying.
*stringent.
?eratolytics effect 0highconcentration1.
Indicated:
caling dermatoses.-omedones acne 0by Vit *
acid1.
7/23/2019 Dermatotherapy
39/56
a. !enicillin can not
recommend because oftheir high potential for
contact sensitiation 7 not
absorbed.
4. */TII"TI- $&
7/23/2019 Dermatotherapy
40/56
b.Tetracyclines :
bacteriostatic
7/23/2019 Dermatotherapy
41/56
d.
7/23/2019 Dermatotherapy
42/56
f. !olymy3in : very broad
pectrum, especially 0%.-oli, !seudomonas *1
g./itrofuraone : bactericidal
7 bacteriostatic
7/23/2019 Dermatotherapy
43/56
h.-lindamycin : broad
spectrum of !enicillin
resistant 7 treatment for
acne.
%g : cleocin, sobelin.
7/23/2019 Dermatotherapy
44/56
a. Tolnaftate : anti8fungal drug
for all dermatophytes.
%g : aftate, tinactin, tonoftal.
@. */TI)/
7/23/2019 Dermatotherapy
45/56
b.b. TolciclateTolciclate : analogue of: analogue of
tolnaftate.tolnaftate.%g : fungifos.%g : fungifos.
c.c. Imidaole derivatesImidaole derivates : for: fordermatophytoses,dermatophytoses, -andida-andida
albicans, !ityriasis versicolor.albicans, !ityriasis versicolor.
%g : canesten, mycospor,%g : canesten, mycospor,
micatin.micatin.
7/23/2019 Dermatotherapy
46/56
d.*mphotericin : anti8fungal
antibiotic, especially for
superficial infections.
%g : fungione, ampho8
moronal.
7/23/2019 Dermatotherapy
47/56
e. /ystatin: no systemic action,
minimally absorbed from
7/23/2019 Dermatotherapy
48/56
a. enyl enoate : anti8
scabies for infants 7
children.
=. !*&*ITI-I$%=. !*&*ITI-I$%
7/23/2019 Dermatotherapy
49/56
b.De3achlorocyclohe3ane :
antiscabies, antipediculosis,
antiphtriasis.
%g : lindane 0gamene, kwell,
scabene1.
7/23/2019 Dermatotherapy
50/56
c. -rotamiton : scabies,
phtriasis, demode3folliculitis, 7 antipruritic
drug.
%g : eura3 lotion, crotamite3
gel.
c. Thiabendaole : creepingeruption, scabies 0E F5;
cases are cleared1.
7/23/2019 Dermatotherapy
51/56
%ffects:
*nti8inflammatory.
*nti8pruritic.
7/23/2019 Dermatotherapy
52/56
a. Mild corticosteroid :
hydrocortisone 5.2 > 6.=;.
b.Moderate corticosteroid :
clobetasone 5.5=;.
@ group classification of
topical corticosteroid :
7/23/2019 Dermatotherapy
53/56
c. !otent corticosteroid :
triamcinolone * 5.2;
betamethasone 2G valerate
5.=;.
d.Digh potency corticosteroid:
fluocinolone acetonide 5.6;.
7/23/2019 Dermatotherapy
54/56
ide effects corticosteroid:
*llergic contact dermatitis.
*trophy 7 thinning of the
epidermis.
teroid acne.teroid striae.
7/23/2019 Dermatotherapy
55/56
'eucoderma.
teroid ulcer 0chronic
venous insufficiency1.
&ebound effect 0psoriasis
vulgaris1.
7/23/2019 Dermatotherapy
56/56